Mija, L. A.; Elkrief, A. Clinical Considerations for the Management of Advanced PD-L1 ≥50% Non-Small Cell Lung Cancer In 2025: Should All Patients Be Treated the Same?. Can Oncol Today 2025, 2, 13–17.